NCT05676463 2026-03-03
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer
Thomas Jefferson University
Phase 2 Terminated
Clinical Trials
14 trialsNCT05733351 2025-09-15
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
Emory University
Phase 1 Terminated
NCT04927663 2025-05-20
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression
University of California, San Francisco
Phase 1 Terminated
NCT04134208 2025-01-16
An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT04928820 2022-10-21
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy
Jonsson Comprehensive Cancer Center
Phase 2 Terminated
NCT04279561 2022-09-21
Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT01816048 2019-12-09
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis
University of Wisconsin, Madison
Phase 2 Terminated
NCT02121600 2019-05-07
18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Terminated
NCT01859338 2018-03-07
Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI
Virginia Commonwealth University
Terminated
NCT02429804 2017-05-30
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Stanford University
Phase 1 Terminated
NCT01761812 2016-10-18
Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods
Sunnybrook Health Sciences Centre
Phase NA Terminated
NCT00429338 2015-01-09
3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00147238 2012-08-07
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00989105 2012-02-28
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
Cancer Research UK
Phase 1 Terminated